These included pathways related to LXR/RXR activation, cardiac hypertrophy signaling, ILK signaling, production of NO and ROS in macrophages, actin cytoskeleton signaling, fibrosis and cell migration pathways, and acute phase response signaling (Figs 6B and 7B). The gene discussed is ILK; the disease is cardiac hypertrophy.